The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and othe

Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy

(2011) ANNA MAYHEW et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy

(2011) D. M. Escolar et al.   NEUROLOGY

Sporadic occurrence of Duchenne Muscular Dystrophy: evidence for new mutation

(2010) C. Thomas Caskey et al.   CLINICAL GENETICS

The Pathomechanics of Gait in Duchenne Muscular Dystrophy

(2010) David H. Sutherland et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

The 6-minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations

(2010) Craig M. MCDonald et al.   MUSCLE & NERVE

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy

(2010) Elena Mazzone et al.   NEUROMUSCULAR DISORDERS

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy

(2009) Craig M. McDonald et al.   MUSCLE & NERVE

Reliability of the North Star Ambulatory Assessment in a multicentric setting

(2009) E.S. Mazzone et al.   NEUROMUSCULAR DISORDERS

Gait pattern in Duchenne muscular dystrophy

(2008) Maria Grazia D’Angelo et al.   GAIT & POSTURE